Last reviewed · How we verify
NCT06090552
I CAN DO Surgical ACP
NA trial testing Letter in Surgical Advanced Care Planning in 6,000 participants. Currently enrolling.
31 August 2028
Quick facts
| Lead sponsor | University of California, San Francisco |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 6,000 |
| Start date | 26 February 2025 |
| Primary completion | 31 August 2028 |
| Estimated completion | 31 August 2028 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Letter
- AD
- PREPARE website
- reminders
- healthcare navigator
Conditions studied
- Surgical Advanced Care Planning — all drugs for Surgical Advanced Care Planning →
Sponsor
University of California, San Francisco
Who can join
65 and older, any sex, with Surgical Advanced Care Planning. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the Advanced Care Planning (ACP) study is to encourage patients aged 65 or older who are referred for elective surgery to have advanced care planning.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
I CAN DO Surgical ACP (Improving Completion, Accuracy and Dissemination of Surgical Advanced Care Planning): a protocol for a multisite, single-blinded, pragmatic randomised controlled trial to improve ACP completion in older adults in the presurgical setting.
Welton L, Colley A, Sudore RL, Melton GB, et al · · 2025 · PMID 40987739 · DOI 10.1136/bmjopen-2025-108850
Verify or expand the search:
- PubMed search for NCT06090552
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Letter
Trials testing the same drug.
- NCT05853848 — Mammogram Mail- and Phone-based Interventions · NA · completed
- NCT05509270 — Efficacy of Communication Modalities for Promoting Flu Shots · NA · completed
- NCT04548765 — Evaluation of Letters Promoting Colorectal Cancer Testing · NA · completed
- NCT04051281 — CMO Letter to Reduce Inappropriate Antibiotic Prescribing Winter 2019/2020 · NA · completed
- NCT05226091 — Trial to Assess Implementation of New Research in a Primary Care Setting (TRAINS) · NA · completed
Other University of California, San Francisco trials
Trials by the same sponsor.
- NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
- NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
- NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
- NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
- NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06090552 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
- Last refreshed: 6 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06090552.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing